机构：[1]Hospital of Chinese People's Liberation Army, Beijing, China[2]The Affiliated Hospital of Qingdao University, Qingdao, China[3]Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, China河北医科大学第四医院[4]The First Hospital of China Medical University, Shenyang, China[5]Jiangsu Province Hospital, Nanjing, China江苏省人民医院[6]Hangzhou First People' Hospital, Hangzhou, China[7]Hangzhou Normal University, Hangzhou, China
第一作者机构：[1]Hospital of Chinese People's Liberation Army, Beijing, China[2]The Affiliated Hospital of Qingdao University, Qingdao, China[3]Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, China[4]The First Hospital of China Medical University, Shenyang, China[5]Jiangsu Province Hospital, Nanjing, China[6]Hangzhou First People' Hospital, Hangzhou, China[7]Hangzhou Normal University, Hangzhou, China
推荐引用方式(GB/T 7714)：
Fu P.,Wang S.,Yao M.,et al.Clinicopathological features and endocrine therapy mode of ER low expression (1%-9%) breast cancer patients in China[J].CANCER RESEARCH.2019,79(4):doi:10.1158/1538-7445.SABCS18-P4-14-14.
APA：
Fu, P.,Wang, S.,Yao, M.,Xiang, A.,Li, J....&Jiang, Z..(2019).Clinicopathological features and endocrine therapy mode of ER low expression (1%-9%) breast cancer patients in China.CANCER RESEARCH,79,(4)
MLA：
Fu, P.,et al."Clinicopathological features and endocrine therapy mode of ER low expression (1%-9%) breast cancer patients in China".CANCER RESEARCH 79..4(2019)
医学